Childhood Cerebral X-Linked Adrenoleukodystrophy More Than 5 Years After Hematopoietic Cell Transplantation: The First Case From Serbia and Southeastern Europe

Journal of Child Neurology

Volumn 25, Issue 12, 2010, Pages 1542-1547

  Potic, Ana ^a   Rovelli, Attilio M ^b   Uziel, Graziella ^c   Kozic, Dusko ^d   Mladenovic, Jelena ^a   Milic Rasic, Vedrana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SAN GERARDO HOSPITAL   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

hematopoietic cell transplantation; peroxisome; proton magnetic resonance spectroscopy; X linked adrenoleukodystrophy

Indexed keywords

ADRENOLEUKODYSTROPHY; ARTICLE; CASE REPORT; CHILD; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; METHODOLOGY; ONSET AGE; SERBIA;

ADRENOLEUKODYSTROPHY; AGE OF ONSET; CHILD; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; SERBIA;

EID: 82255166397     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073810375117     Document Type: Article

References (13)

1. Raymond GV, Naidu S., Moser HW Peroxisomal disorders. In: Swaiman KF, Aschwal S, Ferriero D, eds. Pediatric Neurology: Principles & Practice. St. Louis, MO: Mosby-Year Book; 2006: 746-749.
2. Shapiro E., Krivit W., Lockman L., et al. Long term effect of bone marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet. 2000; 356: 713-718.
3. Moser HW, Loes DJ, Melhem ER, et al. X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. Neuropediatrics. 2000; 31: 227-239.
4. Peters C., Charnas LR, Tan Y., et al. Cerebral X-linked adrenoleukodystrophy: the international haematopoetic stem cell transplantation experience from 1982 to 1999. Blood. 2004; 104: 881-887.
5. Warren DJ, Conolly DJ, Wilkinson ID, et al. Magnetic resonance spectroscopy changes following haematopoetic stem cell transplantation in children with cerebral adrenoleukodystrophy. Dev Med Child Neurol. 2007; 49: 135-139.
6. Aicardi J., Ogier H. X-linked adrenoleukodystrophy. In: Aicardi J, ed. Diseases of Nervous System in Children. London: Mac Keith University Press; 1998: 262-264.
7. Rovelli AM, Steward CG Haematopoetic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions. Bone Marrow Transplant. 2005; 35: 523-526.
8. Peters C. Steward CG on behalf of the National Marrow Donor Program (NMDP), International Bone Marrow Transplant Registry (IBMTR), and the Working Party on Inborn Errors of the European Bone Marrow Transplant Group (EBMT). Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant. 2003; 31: 229-239.
9. Van der Knaap MS, Valk J. X-linked adrenoleukodystrophy. In: Van der Knaap MS, Valk J, eds. Magnetic Resonance of Myelination and Myelin Disorders. Berlin-Heidelberg: Springer-Verlag; 2005: 176-190.
10. Wilken B., Dechent P., Brockmann K., et al. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation. Neuropediatrics. 2003; 34: 237-246.
11. Kennedy DW, Abkowitz JL Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood. 1997; 90: 986-993.
12. Krivit W., Sung JH, Shapiro EG, et al. Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant. 1995; 4: 385-392.
13. Cartier N., Hacein-Bey-Abina S., Bartholomae CC, et al. Hematopoietic stem cell lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009; 326: 818-823.